Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severely Active Psoriatic Arthritis Subjects with Inadequate Response to Disease Modifying anti-Rheumatic Drug Therapy
Epistemonikos ID: b5f7ba15b5cbdf23cd7b68cc0acc84bc9ac149e4
First added on: Feb 15, 2022